Nuvama Wealth Management Limited Grants 93,930 Employee Stock Appreciation Rights
Nuvama Wealth Management Limited announced on May 11, 2026, the approval and grant of 93,930 Employee Stock Appreciation Rights (ESARs) to its eligible employees. The grant is executed under the 'Nuvama Wealth Employee Stock Appreciation Rights Plan 2024'.The plan outlines the framework under which ESARs are provided, ensuring that the rights are granted to eligible employees. The ESARs covered are for a maximum of 93,930 equity shares of the Company.
The plan is administered by the Nomination and Remuneration Committee. ESARs granted, once vested and exercised, will entitle the holder to receive appreciation for a specified number of equity shares. The settlement of this appreciation shall be in the equity shares of the Company upon payment of the exercise price and applicable taxes, in accordance with the terms of the Plan.
Key details regarding the ESAR grant mechanism include:
| Feature | Detail |
|---|---|
| Total ESARs Granted | 93,930 |
| Shares Covered | Not more than 93,930 equity shares |
| Pricing Formula | The average of the daily opening and closing price of the equity shares, as quoted on the Recognized Stock Exchange where trading volume is highest, calculated over the 20 trading days immediately prior to the Relevant Date. |
| Vesting Status | Nil |
| Exercise Period | 2 Years from the date of vesting |
Under the Plan, the exercise of ESARs allows the holder to claim the appreciation value of the shares, with the final settlement occurring in equity shares of the Company.
NUVAMA Stock Price Movement
Nuvama Wealth Management Limited shares today slipped by 1.62% to settle at ₹1598.8. The stock experienced active trading, completing the session on a volume of 901,596 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.